CancerNetwork

What CancerNetwork does

CancerNetwork is a U.S.-based digital media and clinical content platform serving oncology healthcare professionals. Its core product is a web-based news and clinical expertise destination (cancernetwork.com) that delivers oncology news, FDA approval alerts, clinical trial coverage, and global cancer care bulletins to oncologists, cancer researchers, and the broader oncology care team. The platform is organized into four content verticals visible on the site — News, Media, Publications, and Events/Resources — and explicitly segments audience pathways by clinical role (e.g., a dedicated Nurse Practitioners/Physician's Assistants resource).

The product portfolio spans more than fifteen distinct properties, including long-form editorial (Global Bulletin, FDA Approval Alert, peer-reviewed Journals), on-demand multimedia (OncView, Podcasts, Videos, Shorts, Around the Practice, Between the Lines, Face Off, Treatment Algorithms with the Oncology Brothers), recurring event series (Frontline Forum, Satellite Sessions, conference coverage), and credentialed education (Training Academy, CME/CE). Additional monetization-adjacent surfaces include a Career Center job board, a Partners/Sponsored content channel, and specialty resource networks such as The Bispecifics Network. The technology is a standard web content management platform with no public APIs, SDKs, or developer documentation disclosed.

The business model is not transparently disclosed in the available data: pricing is not public, revenue figures are absent, and no paying customer logos are named. Available signal points to a professional healthcare media model with multiple monetization layers — pharma/device sponsorship (explicit "Partners" and "Sponsored" sections), CME/CE accreditation fees, recruitment advertising via the Career Center, and potentially journal subscriptions — but the relative weight of each is unverifiable. Ownership, parent company, headcount, and funding history are all undisclosed, representing material diligence gaps.

Name

CancerNetwork

Legal name

CancerNetwork

Website

https://cancernetwork.com

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

CancerNetwork is a U.S.-based digital oncology media platform that delivers clinical news, FDA approval alerts, peer-reviewed journals, multimedia content, CME/CE education, and live event coverage to oncologists, cancer researchers, and the broader oncology care team.

Ownership category

akta.pro rank

Product category

Oncology Healthcare Professional Media

NAICS

Broadcasting and Content Providers (516), Information (51)

SIC

Services-Health Services (8000)

akta.pro primary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

akta.pro secondary industry

Medical Oncology (HLAKAFAB)

Keywords

• Oncology news
• Clinical oncology content
• Continuing medical education
• Oncology medical journals
• FDA approval coverage

Headquarters

HQ city

Cranbury

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Distribution channels1 record

Marketing channels4 records

Core offering

CancerNetwork operates a digital oncology news and clinical expertise platform that delivers cancer research updates, FDA approval alerts, treatment algorithm discussions, peer-reviewed journal content, podcasts, videos, and continuing medical education (CME/CE) programs. The platform serves oncologists, cancer researchers, and oncology healthcare professionals seeking clinical decision support, regulatory updates, and ongoing professional education across multiple content formats including news, multimedia, journals, and live events.

Product overview

CancerNetwork is a unified oncology news and clinical expertise platform offering a portfolio of content products including news publications (Global Bulletin, FDA Approval Alert, Journals), multimedia content (OncView, Podcasts, Videos, Shorts), educational programs (Training Academy, CME/CE), live events (Conferences, Frontline Forum, Satellite Sessions), and specialized resources (The Bispecifics Network, Career Center). The platform serves medical professionals seeking the latest cancer research, FDA approvals, clinical practice guidance, and continuing education in oncology.

Differentiator

Problem solved

Functional benefit

Products and services

• CME/CE Continuing Education Programs

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves6 records

Expansion highlights6 records

Emerging players

• DocWire News: DocWire News aggregates specialty medical news, including oncology, for HCPs via web content and social channels. It is a partial competitor to CancerNetwork, primarily on the news/content side, with lighter CME and journal presence.
• Oncologist (AlphaMed Press / Wiley): The Oncologist is a peer-reviewed oncology journal with companion digital content targeting practicing oncologists. It overlaps with CancerNetwork's journal and clinical-update offerings but is primarily a society-affiliated publication rather than a multi-format media platform.

Regional players

• ECancer (ecancer): ecancer is an open-access oncology publisher headquartered in Europe, providing peer-reviewed journals, news, and CME. It is comparable to CancerNetwork in content mix but competes primarily outside the U.S. market.

Broad incumbents

• Medscape Oncology: Medscape (WebMD/Internet Brands) is the largest physician media platform in the U.S. and operates a dedicated oncology vertical. It overlaps with CancerNetwork on HCP oncology news, CME, and reference content but as part of a much broader multi-specialty portfolio.
• ASCO Daily News: ASCO Daily News is the official news publication of the American Society of Clinical Oncology, covering meeting coverage and clinical updates. It competes with CancerNetwork for oncology HCP attention but with the advantage of society affiliation and exclusive meeting access.

Direct peers

• OncLive: OncLive is the leading U.S. oncology HCP media platform operated by MJH Life Sciences, offering news, peer-reviewed perspectives, podcasts, videos, and live events — directly comparable in audience, content mix, and business model to CancerNetwork.
• Targeted Oncology: Targeted Oncology (formerly OncologyLive's sister brand) provides oncology news, conference coverage, and HCP education focused on targeted therapies — closely aligned with CancerNetwork's clinical-updates and FDA-approval positioning.
• MDedge Hematology-Oncology: MDedge (Frontline Medical Communications) provides specialty-focused news, journals, and CME for hematologists and oncologists, overlapping closely with CancerNetwork's clinical-updates and journal product lines.
• Cancer Therapy Advisor: Cancer Therapy Advisor (Haymarket Media) delivers oncology news, treatment updates, and CME/CE content to practicing oncologists — a near-direct editorial and commercial peer to CancerNetwork's news-plus-CME mix.
• Healio Oncology: Healio (SLACK Inc.) publishes peer-reviewed oncology journals, news, and CME for HCPs, with a content portfolio and CME-heavy model directly comparable to CancerNetwork's journals and Training Academy offerings.

Market position

Strengths5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/CancerNetwrk
• Facebookfacebook.com/Cancer-Network-124530046330
• LinkedInlinkedin.com/company/cancer-network

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CancerNetwork